Loading analysis...
Loading Truth Social...
Loading live updates...
—
S&P 500— —
Nasdaq— —
Dow Jones— —
载入时间机器…
NTRA 最新新闻
NTRA 的最新新闻报道,汇总自华尔街日报、彭博、纽约时报、金融时报与 Google 新闻,实时更新,免费无广告。标题保留原文。
- How FDA Breakthrough Status For Natera’s Multi‑Cancer Test (NTRA) Has Changed Its Investment Story
- Natera (NTRA) Stock May Be 33% Below Fair Value Despite FDA Breakthrough News
- Natera (NTRA) Could Be 33% Undervalued Following FDA Breakthrough Device Designation
- Why Natera (NTRA) Stock Is Up Today
- Natera: Priced To Perfection Amidst Rising Competitive Threats (NASDAQ:NTRA)
- $1000 Invested In Natera 10 Years Ago Would Be Worth This Much Today
- Natera CEO Steven Chapman sells $526k in common stock
- Natera president Solomon Moshkevich sells $1.24m in shares
- $1000 Invested In Natera 5 Years Ago Would Be Worth This Much Today
- Hewlett Packard, Natera, UnitedHealth Group: CNBC ‘Final Trades’ - UnitedHealth Group (NYSE:UNH)
- Natera director Sheena’s trusts dispose of $7.0m in NTRA stock
- RBC Capital raises Natera stock price target on MRD testing growth
- RBC Raises Price Target on Natera to $460 From $350, Keeps Outperform Rating
- Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx
- Why Is Natera (NTRA) Stock Soaring Today
Settings
Appearance
Card Style
Language
Notifications
Live View Style
Trump Truth Social
About
Version
2.6.1
Data Source
r/wallstreetbets
AI Engine
ChatGPT/Gemini/Claude
MCP Server
https://mcp.sellthenews.org/mcp
Contact Us
[email protected]